Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 20:47:35 UTC |
---|
Update Date | 2021-09-26 22:50:39 UTC |
---|
HMDB ID | HMDB0243543 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (+)-Pentazocine |
---|
Description | (+)-Pentazocine, also known as fortral or lexir, belongs to the class of organic compounds known as 2,6-dimethyl-3-benzazocines. These are aromatic compounds containing a 6,7-benzomorphan skeleton, which is substituted by methyl group at the 2- and 6-positions. Based on a literature review a significant number of articles have been published on (+)-Pentazocine. This compound has been identified in human blood as reported by (PMID: 31557052 ). (+)-pentazocine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (+)-Pentazocine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3 |
---|
Synonyms | Value | Source |
---|
Fortral | HMDB | Hydrochloride, pentazocine | HMDB | Lactate, pentazocine | HMDB | Lexir | HMDB | Pentazocine | HMDB | Pentazocine hydrochloride | HMDB | Pentazocine lactate | HMDB |
|
---|
Chemical Formula | C19H27NO |
---|
Average Molecular Weight | 285.431 |
---|
Monoisotopic Molecular Weight | 285.209264493 |
---|
IUPAC Name | 1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol |
---|
Traditional Name | 1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C |
---|
InChI Identifier | InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3 |
---|
InChI Key | VOKSWYLNZZRQPF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 2,6-dimethyl-3-benzazocines. These are aromatic compounds containing a 6,7-benzomorphan skeleton, which is substituted by methyl group at the 2- and 6-positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | 6,7-benzomorphans |
---|
Sub Class | 2,6-dimethyl-3-benzazocines |
---|
Direct Parent | 2,6-dimethyl-3-benzazocines |
---|
Alternative Parents | |
---|
Substituents | - 2,6-dimethyl-3-benzazocine
- 4-hydroxy-6,7-benzomorphan
- Benzazocine
- Tetralin
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Benzenoid
- Tertiary amine
- Tertiary aliphatic amine
- Organoheterocyclic compound
- Azacycle
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Pentazocine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00xr-4490000000-cdeaa3483e4960294eea | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Pentazocine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Pentazocine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (+)-Pentazocine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 10V, Positive-QTOF | splash10-000i-0090000000-d8b868dd7ee8288c688e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 20V, Positive-QTOF | splash10-00kr-0090000000-cc7746a57501b760712b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 40V, Positive-QTOF | splash10-0006-9100000000-6d55598f9401c6ee7e64 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 10V, Negative-QTOF | splash10-001i-0090000000-c2113612e96dcf956da5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 20V, Negative-QTOF | splash10-001i-1090000000-85f9f3b59ab5b6ed8ec1 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (+)-Pentazocine 40V, Negative-QTOF | splash10-0uxr-0390000000-469be370c5a5fdd7637f | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|